D.E. Shaw & Co
HCAQ

D.E. Shaw & Co’s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares HCAQ Stock Holding History

D.E. Shaw & Co’s Portfolio HCAQ Stock Details HCAQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-860,992
Closed -$8.52M – 5883
2021
Q3 		$8.52M Buy
860,992
+15,170
+2% +$150K 0.01% 1637
2021
Q2 		$8.33M Buy
845,822
+827,081
+4,413% +$8.18M 0.01% 1649
2021
Q1 		$187K Buy
+18,741
New +$192K ﹤0.01% 3864

D.E. Shaw & Co's HCAQ Position: Q4 2021 in Review

D.E. Shaw & Co sold out of HealthCor Catalio Acquisition Corp. Class A Ordinary Shares (HCAQ) in Q4 2021, closing a stake of 860,992 shares — an estimated $8.52M sold.

D.E. Shaw & Co first reported a position in HCAQ in Q1 2021 and held it in 3 quarters. The position peaked at $8.52M in Q3 2021. 0 funds tracked by Wall St. Rank hold HCAQ as of Q4 2021.

  • D.E. Shaw & Co reported no remaining HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 860,992 HealthCor Catalio Acquisition Corp. Class A Ordinary Shares shares in Q4 2021, an estimated $8.52M.
  • D.E. Shaw & Co first reported a position in HealthCor Catalio Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 3 quarters.
  • D.E. Shaw & Co's HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position peaked at $8.52M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held HealthCor Catalio Acquisition Corp. Class A Ordinary Shares as of Q4 2021.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.